MidWestOne Financial Group, Inc. Reports Financial Results for the Third Quarter of 2025 IOWA CITY, Iowa, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MidWestOne Financial Group, Inc. (Nasdaq: MOFG) ("we," "our," or the "Company") today reported results for the third quarter of 2025. Third Quarter 2025 Summary1 Net income of $17.0 million, or $0.82 per diluted common share. Adjusted earnings of $18.1 million, or $0.872 per common share. Noninterest income was $10.3 million, which included a negative MSR valuation adjustment of $611 thousand.Noninterest expense was $37.6 million, which included a $...
Nicolet Bankshares, Inc. Announces Merger with MidWestOne Financial Group, Inc. Combination creates premier community banking franchise in the Upper Midwest GREEN BAY, Wis. and IOWA CITY, Iowa, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nicolet Bankshares, Inc. (NYSE: NIC) (“Nicolet”) and MidWestOne Financial Group, Inc., (NASDAQ: MOFG) (“MidWestOne”) jointly announced today the execution of a definitive merger agreement pursuant to which Nicolet will acquire MidWestOne and its wholly-owned banking subsidiary, MidWestOne Bank. Based on the financial results as of September 30, 2025, the combine...
SAIC Announces CEO Transition SAIC Director and Seasoned Government Services Executive James Reagan Appointed Interim CEO Company Reaffirms Fiscal Year 2026 Guidance RESTON, Va., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corporation (Nasdaq: SAIC), a premier Fortune 500® company driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced that the Company’s Board of Directors has appointed James (“Jim”) Reagan as Interim Chief Executive Officer, effective immediately. Mr. Reagan succeeds Toni Townes...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Armada Hoffler Announces Appointment of Shawn J. Tibbetts as Chairman of the Board of Directors Unified leadership structure reflects Board confidence and continued commitment to disciplined growth and shareholder value VIRGINIA BEACH, Va., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) today announced that its Board of Directors unanimously voted to appoint Shawn J. Tibbetts as Chairman of the Board, effective January 1, 2026. This action completes the last phase of the planned succession changes initiated in 2024. In addition to his new role, Tibbetts will continue leadi...
MidWestOne Financial Group, Inc. Announces Third Quarter 2025 Earnings Conference Call IOWA CITY, Iowa, Oct. 10, 2025 (GLOBE NEWSWIRE) -- MidWestOne Financial Group, Inc. (Nasdaq: MOFG) (“MidWestOne” or the “Company”), parent company of MidWestOne Bank, today announced that its third quarter 2025 financial results will be released after market closes on Thursday, October 23, 2025. The Company will host a conference call to discuss its financial results at 11:00 a.m. Central Time on Friday, October 24, 2025. Investors and analysts interested in participating in the call may pre-register u...
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Austria. The Company's application to European regulators has been formally approved, adding Austria as an approved country in FLAMINGO-01 in addition to ...
SAIC to Acquire SilverEdge Government Solutions Move bolsters SAIC’s leading role of bringing commercial-grade technologies and solutions to advance national security missions and operations RESTON, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: ), a leading mission integrator supporting defense, space, intelligence and civilian agencies, announced today it has entered into a definitive agreement to acquire SilverEdge Government Solutions (“SilverEdge”) from private equity firm Godspeed Capital for $205 million in cash. SilverEdge is an innovat...
Armada Hoffler to Report Third Quarter Earnings on November 3rd VIRGINIA BEACH, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) will report its earnings for the quarter ending September 30, 2025 at approximately 4:00 p.m. Eastern on Monday, November 3, 2025. At 8:30 a.m. Eastern on Tuesday, November 4, 2025, senior management will host a conference call and webcast to discuss earnings and other information. To listen to the call, dial (+1) 800-549-8228 (toll-free dial-in number) or (+1) 646-564-2877 (toll dial-in number). The conference ID is 93777. The conference call ...
Tile Shop’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (“Tile Shop” or the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials and related accessories, today announced that the Independent Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company (the “Board”) comprised of independent directors has recommended, and the Board has approved, a plan to delist its shares of...
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Belgium. The Company's application to European regulators has been formally approved, adding Belgium as an approved country in FLAMINGO-01 in addition to...
Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the expansion of FLAMINGO-01 clinical trial to Portugal. The Company's application to European regulators has been formally approved, adding Portugal as an approved country in FLAMINGO-01 in addition...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.